Clinical Trial Update: Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 pharmacodynamic comparison of PL2200 versus enteric-coated aspirin in adults with type 2 diabetes; the trial status is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (enteric-coated) (acetylsalicylic acid)
• PL2200

Snippet

Sponsor: PLx Pharma | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-09-04